Drug manufacturers reported their list prices, which do not include discounts or rebates, as of the first quarter 2019 to California’s Office of Statewide Health Planning and Development.
| Drug Manufacturer |
Latest price | Change |
|---|---|---|
| Ativan Tablets 1mg 1,000s | ||
| Valeant Pharmaceuticals North America | $32,336.20 | $25,461.16 or +370.34% since 2014 |
| Xenazine 25.0mg. 112 Tablets | ||
| Lundbeck | $28,198.58 | $17,165.17 or +155.57% since 2014 |
| LEU TechneLite* (Technetium Tc99m Generator) | ||
| Lantheus Medical Imaging | $26,203.96 | $8,346.90 or +46.74% since 2015 |
| Afinitor* Disperz 5mg | ||
| Novartis | $15,706.71 | $7,610.94 or +94.01% since 2014 |
| Hetlioz 20 mg capsules; bottles of 30 | ||
| Vanda Pharmaceuticals | $15,701.35 | $8,682.10 or +123.69% since 2015 |
| Quadramet (Samarium Sm 153 Lexidronam Injection) | ||
| Lantheus Medical Imaging | $15,217.64 | $7,223.64 or +90.36% since 2015 |
| Sprycel (dasatinib)* 50 MG Tablet, Bottle of 60 Tablets | ||
| Bristol-Myers Squibb | $15,187.87 | $5,742.45 or +60.80% since 2014 |
| Tasigna 50mg | ||
| Novartis | $14,735.62 | $1,091.53 or +8.00% since 2019 |
| Sabril 500mg. 100 Tablets | ||
| Lundbeck | $14,611.73 | $8,975.63 or +159.25% since 2014 |